Related Experiment Video
Updated: Jul 22, 2025

08:31
Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.1K
PharmaChain: Blockchain-based drug supply chain provenance verification system
Sarmistha Sarna Gomasta1, Aditi Dhali1, Tahlil Tahlil2
1Department of Computer Science and Engineering, Jahangirnagar University, Bangladesh.
Heliyon
|July 24, 2023
Summary
Counterfeit drugs threaten public health. PharmaChain, a new blockchain framework, enhances pharmaceutical traceability and security, safeguarding the drug supply chain.
Area of Science:
- Blockchain Technology
- Supply Chain Management
- Pharmaceutical Science
Background:
- Pharmaceutical companies face challenges in standardizing product traceability.
- Counterfeit drugs pose a significant risk to public health and the pharmaceutical industry.
- An end-to-end tracking system is essential for drug safety and combating counterfeit products.
Purpose of the Study:
- Introduce PharmaChain, a decentralized framework for pharmaceutical supply chain traceability.
- Leverage blockchain technology for enhanced confidentiality, accountability, and interoperability.
- Improve drug traceability to prevent counterfeit pharmaceuticals and protect public health.
Main Methods:
- Developed PharmaChain using a decentralized Hyperledger Fabric framework.
- Implemented on-chain and off-chain storage for secure and rapid transactions.
- Utilized smart contracts for data provenance and employed elliptic curve digital signature algorithm, hash data encryption, and a 33% node attack simulation for security demonstration.
Main Results:
- PharmaChain provides a secure and transparent platform for pharmaceutical product tracking.
- The framework demonstrates robust security features against potential threats.
- Smart contracts ensure data integrity and provenance throughout the supply chain.
Conclusions:
- PharmaChain offers an effective solution for improving drug traceability in the pharmaceutical supply chain.
- The proposed framework enhances security and accountability, crucial for preventing counterfeit drugs.
- Implementing PharmaChain can significantly contribute to preserving public health by ensuring drug authenticity.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
5.7K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.7K
Drug Distribution: Overview
214
Drug distribution within the body is a dynamic process involving the movement of a drug in two directions across various compartments: from the bloodstream into tissues (tissue uptake) and from tissues back into the bloodstream (tissue release or redistribution). This process is passive and primarily driven by two variables: the concentration gradient between the bloodstream and the extravascular tissues and the drug's ability to cross the cell membrane.
Initially, the free drug in the...
Initially, the free drug in the...
214
Pharmacovigilance
895
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
895
Drug Biotransformation: Overview
2.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.5K
Drug Delivery: Overview
326
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
326
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K

